BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papadopoli R, De Sarro C, Torti C, Pileggi C, Pavia M. Is There Any Opportunity to Provide an HBV Vaccine Booster Dose Before Anti-Hbs Titer Vanishes? Vaccines (Basel) 2020;8:E227. [PMID: 32429396 DOI: 10.3390/vaccines8020227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Papadopoli R, De Sarro C, Palleria C, Gallelli L, Pileggi C, De Sarro G. Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population. Vaccines (Basel) 2021;9:1494. [PMID: 34960240 DOI: 10.3390/vaccines9121494] [Reference Citation Analysis]
2 Trovato CM, Montuori M, Sansone A, Morelli A, Russo G, Pietropaoli N, Oliva S. Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children. Vaccines (Basel) 2021;9:101. [PMID: 33525661 DOI: 10.3390/vaccines9020101] [Reference Citation Analysis]
3 Bekele Y, Berzofsky JA, Chiodi F. Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals. Vaccines (Basel) 2021;9:1484. [PMID: 34960230 DOI: 10.3390/vaccines9121484] [Reference Citation Analysis]